Liver Fibrosis and NAS scoring from CT images using self-supervised learning and texture encoding
Authors:
Ananya Jana,
Hui Qu,
Carlos D. Minacapelli,
Carolyn Catalano,
Vinod Rustgi,
Dimitris Metaxas
Abstract:
Non-alcoholic fatty liver disease (NAFLD) is one of the most common causes of chronic liver diseases (CLD) which can progress to liver cancer. The severity and treatment of NAFLD is determined by NAFLD Activity Scores (NAS)and liver fibrosis stage, which are usually obtained from liver biopsy. However, biopsy is invasive in nature and involves risk of procedural complications. Current methods to p…
▽ More
Non-alcoholic fatty liver disease (NAFLD) is one of the most common causes of chronic liver diseases (CLD) which can progress to liver cancer. The severity and treatment of NAFLD is determined by NAFLD Activity Scores (NAS)and liver fibrosis stage, which are usually obtained from liver biopsy. However, biopsy is invasive in nature and involves risk of procedural complications. Current methods to predict the fibrosis and NAS scores from noninvasive CT images rely heavily on either a large annotated dataset or transfer learning using pretrained networks. However, the availability of a large annotated dataset cannot be always ensured andthere can be domain shifts when using transfer learning. In this work, we propose a self-supervised learning method to address both problems. As the NAFLD causes changes in the liver texture, we also propose to use texture encoded inputs to improve the performance of the model. Given a relatively small dataset with 30 patients, we employ a self-supervised network which achieves better performance than a network trained via transfer learning. The code is publicly available at https://github.com/ananyajana/fibrosis_code.
△ Less
Submitted 15 March, 2021; v1 submitted 5 March, 2021;
originally announced March 2021.
Deep Learning based NAS Score and Fibrosis Stage Prediction from CT and Pathology Data
Authors:
Ananya Jana,
Hui Qu,
Puru Rattan,
Carlos D. Minacapelli,
Vinod Rustgi,
Dimitris Metaxas
Abstract:
Non-Alcoholic Fatty Liver Disease (NAFLD) is becoming increasingly prevalent in the world population. Without diagnosis at the right time, NAFLD can lead to non-alcoholic steatohepatitis (NASH) and subsequent liver damage. The diagnosis and treatment of NAFLD depend on the NAFLD activity score (NAS) and the liver fibrosis stage, which are usually evaluated from liver biopsies by pathologists. In t…
▽ More
Non-Alcoholic Fatty Liver Disease (NAFLD) is becoming increasingly prevalent in the world population. Without diagnosis at the right time, NAFLD can lead to non-alcoholic steatohepatitis (NASH) and subsequent liver damage. The diagnosis and treatment of NAFLD depend on the NAFLD activity score (NAS) and the liver fibrosis stage, which are usually evaluated from liver biopsies by pathologists. In this work, we propose a novel method to automatically predict NAS score and fibrosis stage from CT data that is non-invasive and inexpensive to obtain compared with liver biopsy. We also present a method to combine the information from CT and H\&E stained pathology data to improve the performance of NAS score and fibrosis stage prediction, when both types of data are available. This is of great value to assist the pathologists in computer-aided diagnosis process. Experiments on a 30-patient dataset illustrate the effectiveness of our method.
△ Less
Submitted 22 September, 2020;
originally announced September 2020.
